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Myelinated  cultures  of  rat  and  mouse  cerebellum  undergo  a  specific and 
characteristic pattern  of demyelination in  the presence  of sera from animals 
with  experimental  allergic  encephalomyelitis  (EAE)  (1,  2).  The  neuroglia 
swell; myelin sheaths become disfigured by fusiform swellings and break away 
as small fragments; and finally, remaining intact sheaths and myelin fragments 
are reduced to small fat droplets. During this process neuron somas and axons 
appear little affected (Figs. 1 to 4). 
This communication will present evidence for an immunological mechanism 
responsible for the in vitro demyelination. 
Methods 
The techniques of rat cerebellar tissue culture, induction of EAE in animals, and the prepa- 
ration of sera have been previously described  (1). An additional technique  was employed to 
develop  a  series of animals with varying incidence of clinical and pathological lesions and 
varying levels of circulating antibodies. Each of 10 rabbits received 3 intraperitoneal inocula- 
tions of bovine cord (250 mg each) over a 3 month period: 5 animals with cord suspension in 
Freund's adjuvant; and the remaining 5, with cord in saline. Four of the 5 animals inoculated 
with cord in adjuvant developed  hindleg weakness  following the third inoculation,  which 
progressed over 2 to 4 weeks to complete paraplegia, urinary and fecal incontinence, and death. 
At autopsy, 4 months after the first inoculation,  characteristic lesions of EAE were found. 
Two of the remaining animals, i.e. without adjuvant, developed hindleg weakness and ataxia 
following the third inoculation.  However, at autopsy, 4 months after the first inoculation and 
2 weeks after serum examination and the appearance of symptoms, no microscopic nervous 
system changes were noted. 
Preparation of Serum Fractions.--The globulins were prepared by sodium sulfate or am- 
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monium sulfate fractionation of whole sera. Both globulin and albumin fractions were dialyzed 
against 0.01 ~ phosphate-buffered saline, pH 7.2, and passed through a Millipore filter. Gamma 
2 globulin (comparable to the 7S fraction) was prepared from the active sera of 3 rabbits with 
known EAE by Dr. S. Kochwa of the Department of Hematology of Mount Sinai Hospital, 
using a  DEAE cellulose column and elution with 0.02 ~  phosphate buffer (pH 6.3)  (3). The 
remaining serum proteins were eluted with 1 ~  NaC1.  Both fractions were made isotonic and 
passed through a Millipore filter. 
Sera were heated to 56°C for 20 to 30 minutes to inactivate the C'I and C% and dirnlrai~]l 
the activity of the C'3 and C'4 components of complement (4). Other EAE sera were incu- 
bated with 0.15 N NI-I,OH at 37°C for 11/~ hours and neutralized with 0.15 N HC1 to inactivate 
the C'4 component of complement (4). 
Exposure of Sera to Homologous and Helerologous Tissue.--Sera were exposed to homologous 
and heterologous tissues as indicated in Table I. Rabbit and rat brain suspensions were pre- 
pared (75, 37, and 10 mg/cc) and incubated with 1.0 cc of EKE serum for 12 hours at 370C 
and centrifuged at 8000 m,~ at 4°C for 2 hours. All control tissues, i.e. RBC, lung, liver, kid- 
ney, were treated in a similar manner. Rabbit and rat RBC were collected in a heparin-rinsed 
syringe, washed with buffered saline and diluted to a final concentration of 1,000,000  cells per 
TABLE  I 
Exposure of EAE Sera to Homologous and Hedetologous Tissue 
No. cultures 
Tissue  Species  Sera  demyelinating 
1.  RBC 
2.  Lung 
3.  Liver 
4.  Kidney 
5.  Brain 
Rabbit, rat 
Rabbit, rat 
Rabbit, rat 
Rat, guinea pig 
Rabbit, rat, bovine cord 
Rabbit 
Rabbit 
Rabbit 
Rabbit 
Rabbit 
6/6 
6/6 
3/3 
12/12 
o/12 
mm (3). One ec EAE serum or pooled EAE globulin was exposed to 1 cc of cells.  Rabbit and 
rat lung were removed under sterile conditions and  homogenized in buffered  saline  (find 
concentration 100 mg/cc). Suspensions containing 100 and 50 mg were exposed to 1 cc of EAE 
serum. Freshly homogenized as well as acetone-dried liver (150 mg/cc former; and 100 mg/cc 
latter) were exposed to 1 cc of EAE serum. Rat and guinea pig kidneys were homogenized in 
buffered saline (250 mg/cc) and exposed to 1 cc of EAE serum or globulin. Polylysine (1 rag) 
(kindly supplied by Dr. Stephen Komguth) was added to 1 cc of EAE serum, incubated at 
37°C for 12 hours, and centrifuged at 7000 g at 4°C for 2 hours. 
ApplivaHon of S~ra and  Protein Fravtions to Culture~.--All  normal and  EAE  sera  were 
tested for sterility and discarded if contaminated. Globulin and albumin fractions were passed 
through a  Millipore filter. All  specimens were stored frozen. For testing they were added to 
aliquots of the usual feeding solution in concentrations ranging from 5 to 40 per cent. Where 
the sera had been fractionated or exposed to tissue, the specimens were tested with and without 
normal fresh serum as a  source of complement. The various test and control mixtures were 
used to feed established, randomly distributed, myelinated sister cultures of rat cerebellum. 
The cultures were subsequently observed for periods of time ranging from 6 hours to more than 
1 month. After a period of observation, they were either washed in balanced salt solution and 
returned to normal nutrient or were fixed for staining. 
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in 0.01 ~  phosphate-buffered saline for 15 minutes. They were fixed  for 30 seconds in 95 per 
cent alcohol or for 10 minutes in cold acetone. Occasionally they were used unfixed. They were 
then overlayed with duck  anti-rabbit globulin globulin, duck  anti-rabbit albumin globulin 
(supplied by Dr.  Konrad Hsu),  or goat anti-rabbit globulin globulin (lot 409,  Progressive 
Lab., Baltimore) conjugated with fluorescein isothiocyanate. As a control, demyelinating cul- 
tures were initially exposed to unlabeled duck anti-rabbit globulin globulin and subsequently 
to labeled anti-globulin. All such cultures were examined with a Leitz fluorescence microscope 
and photographed on Ektachrome or royal X  pan film exposed for 3 to 5 minutes. 
Frozen Section Imubation.--Normal rabbit and rat spinal cord, brain stem, and cerebellum 
were quick frozen in isopentane and dry ice, sectioned on a microtome at --20°C at 10 to 20 
microns, and thawed at room temperature. The sections were then incubated with normal 
and known EAE-demyelinating sera in 50 per cent concentrations in normal feeding solution 
for 12 to  18 hours at 35°C.  Sections were then washed in buffered saline, fixed in buffered 
formalin, and stained with the inxol-fast blue stain. 
RESULTS 
In addition to  the sera  of 12 rabbits  tested  on 366 cultures  previously  reported 
(I),  the sera  of 2 rats,  8 mice,  and 15 guinea pigs  were tested  on approximately 
200 myelinated cultures  of rat  or mouse cerebellum.  The 2 rats  had been inocu- 
lated with rat spinal  cord and, following  the appearance of symptoms, the sera 
were removed and applied to myelinated cultures  of rat cerebellum. The pre- 
viously described pattern of demyelination  was observed when either homol- 
ogous or heterologous systems were employed (1).  The spinal  fluid  of 1 rabbit 
with EAE  was also  tested and produced the specific  pattern of demyelination 
associated with the EAE sera. 
The sera of 12 additional rabbits were tested on 193 cultures (Table II). The 
sera of all animals with lesions and clinical symptoms of EAE and of 2 animals 
with clinical but no pathological evidence of the disease, possessed myelinotoxic 
factors. Four animals without symptoms or lesions produced no demyelinating 
substances. 
Heating the sera to 56°C for 20 to 30 minutes or treating with NH4OH with 
subsequent neutralization removed all myelinotoxic activity. In all cases, ac- 
tivity was completely restored by the addition of normal fresh serum as a source 
of complement. 
In the presence  of complement, the salt-precipitated globulin fractions of 
EAE sera demonstrated the myelinotoxic activity of the entire serum, whereas 
the albumin and alpha globulin fractions were entirely negative. In the absence 
of complement,  the globulin was inactive. The myellnotoxic activity of the 
DEAE  column eluents was entirely in  the gamma 2 globulin (7S)  fraction, 
while the remaining fractions were inactive. By dilution with buffered saline, 
it was determined that in ~tro demyelination could occur within 24 hours with 
less than 1 microgram of gamma 2 globulin. 
Exposure of EAE sera or globulin to rabbit or rat brain homogenates ac- 
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toxic activity. When conditions of exposure were changed, such as reducing the 
time of exposure to 1 hour and centrifuging at lower speeds, the demyelinating 
activity was not appreciably lowered. Exposure to homologous or heterologous 
RBC, liver, lung, and kidney for greater than 6 hours did not remove any of the 
specific myelinotoxic activity. In fact, on exposure to rat liver it was felt that 
the onset of demyelination appeared slightly earlier than in unabsorbed active 
EAE sera. 
TABLE II 
Correlation of EAE and in Vitro Dernyelination 
Rabbit  Clinical 
symptoms  Path.  lesions 
No. of cultures which demyelinate with serum 
Preinoculation  Postinoculation 
Group I. Rabbits inoculated with bovine cord without adjuvant 
1.  2-79 
2.  2-89 
2.  2-97 
4.  208 
5.  7-36 
0 
+ 
+ 
0 
0 
0 
0 
0 
0 
0 
0/3 
0/3 
0/3 
Not tested 
o/9 
0/6 
3/3 
6/6 
0/6 
0/9 
1.9 
2.  11 
3.  2-83 
4.  2-87 
5.  2-93 
6.  2-94 
7.  2-95 
Grou ) II. Rabbits inoculated with bovine cord with adjuvant 
+  I  +  +  + 
+  + 
+  + 
0  0 
4-  4- 
4-  + 
0/12 
0/4 
0/6 
O/6 
0/3 
0/9 
0/3 
24/24 
21/21 
24/24 
6/6 
0/6 
15/15 
6/6 
Addition  of  polylysine  to  EAE  sera  produced  an  immediate  precipitate. 
However,  the  myelinotoxic activity in  the  supernatant  was  completely pre- 
served. One mg of polylysine in itself produced no morphological alteration of a 
normal healthy myelinated culture. Thus, in ~tro there appears to be no affinity 
of the demyelinating factor for a non-specific basic protein, nor does the protein 
initiate or facilitate demyelination in vitro as it has been demonstrated to do 
in vivo  (5). 
Whereas  heparin  alone  had  no  effect  on  cultures,  it  interfered  with  the 
demyelinative  activity  of  a  known  positive  sera.  An  experiment  was  con- 
structed to determine whether the effect of heparin depended on binding to the 
myelin sheath  (perhaps to a  postulated basic protein, reference 6)  or whether 
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cultures  were exposed to  100  units  of heparin.  Another  three  cultures  were 
exposed to 100 units  of heparin plus  10 per cent EAE  serum.  At  the end of 
72  hours,  the myelin sheaths  in all six cultures appeared unchanged. At  this 
time, the cultures were washed. Those previously exposed to heparin alone were 
now exposed to EAE serum alone. The three cultures previously exposed to 
heparin plus EAE serum were now exposed to normal fresh serum. All six cul- 
tures demyelinated within 4  to 6  hours. These results are consistent with  an 
action of heparin on complement and suggest  that  EAE globulin rather than 
heparin had attached to the myelin sheath. 
Normal as well as EAE serum had no effect upon unfixed frozen sections of 
rabbit and rat  CNS. Myelin as well as adjacent glia appeared unchanged as 
determined by the luxol-fast blue stain. There was no evident swelling, frag- 
mentation, or myelinolysis in the section; whereas  such  changes  were striking 
with  the same sera applied in  similar  concentration  to  myelinated  cultures 
of rat cerebellum. 
Fluorescent  Microscopy.--Approximately  135  cultures  were  exposed  to 
various sera and then treated with anti-rabbit globulin or anti-rabbit albumin 
conjugated with fluorescein isothiocyanate. The pattern observed has had the 
following consistent features: 
1.  Mter  short  term  exposure  to  EAE  serum  and  prior  to  demyelination, 
cultures stain positively for globulin on the myelin sheath as well as on the 
surface of some neuroglial cells (Fig. 5). 
2.  As  fusiform  swellings  and  fragmentation  occur  during  the  process  of 
demyelination, the fluorescent antiglobulin appears on these ballooned mem- 
branes  as  well  as  diffusely  throughout  the  cytoplasm  of  many  clusters  of 
neuroglial cells (Figs. 6 to 9). 
3.  Cultures  which  were  unaffected  after  treatment  with  heat-inactivated 
EAE rabbit sera also stained positively for globulin on glial surface membranes. 
Myelin sheath staining was present but was far less intense unless a  source of 
complement had been added. 
4.  Cultures  unaffected  by  treatment  with  normal  rabbit  sera  or  normal 
feeding solution demonstrated a  pattern  of antiglobulin  staining  which  was 
punctate and sparse. Often no observable staining was present (Fig. 10). 
5.  All cultures exposed to EAE or normal serum responded to staining for 
albumin with a  similar punctate distribution. 
In  demyelinated cultures and  cultures exposed to heat-inactivated serum, 
myelin sheath, and neuroglial membrane localization of fluorescent antiglobin 
could be blocked by prior treatment of the culture with unlabeled duck and 
anti-rabbit globulin. The punctate activity, however, could not be completely 
blocked. This may indicate that a portion of this response is due to pinocytosis 
by incompletely fixed cells or to inadequate washing of the fluorescent-stained 
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The consistent and specific localization of globulin on the myelin sheath and 
glial cell membrane during the process of demyelinafion represents  the most 
conspicuous and characteristic  feature of the fluorescent antibody study. 
DISCUSSION 
Although several patterns of glial, neuronal,  and myelin sheath alterations 
have resulted from the action of different  agents on cultured rat and mouse 
cerebellum  (22), the  response  to  serum  from  animals  with  EAE  remains 
unique and follows a  consistent  and predictable  morphological pattern. The 
data from the present experiments suggest an antigen-antibody reaction as the 
mechanism responsible for this in vitro demyelination: 
1.  The system is complement dependerrl~. 
2.  In the presence of complement, the serum globulins or, more specifically, 
their gamma 2 globulin fractions, possess the same activity as the whole serum. 
The remaining fractions are inactive. 
3.  Exposure to homologous or heterologous brain removes the total activity, 
whereas homologous or heterologous non-nervous tissue does not. 
4.  Fluorescent antibody studies  localize the EAE globulin  on the myelin 
sheath and glial cell membranes  during the process of demyelination. 
No gross morphological alteration occurs in frozen sections of adult rabbit 
and rat spinal  cord incubated with EAE serum although the EAE globulins 
are localized on the myelin sheaths (8, 9). It appears,  therefore, that the EAE 
effect is not simply due to the action of a myelinotoxic serum enzyme. It would 
seem, rather, that demyelination of the cultured tissues results from a complex 
interaction involving antibody, complement and the living myelin sheaths and 
neuroglia.  Whether or  not the initial event of in  vitro  demyelination is  an 
antigen-antibody  reaction affecting the myelin sheath or the glial cell membrane 
directly cannot  be  determined from the  fluorescent  antibody experiments. 
Preliminary  electron  microscopic  observations  suggest  that  morphological 
alterations in neuroglial  cytoplasmic  constituents may precede  those  of the 
myelin sheath (7, 10). Biochemical changes of the myelin sheath might be pres- 
ent, however, and be undetected by the techniques  employed. 
That gamma 2 globulins and complement in the sera of animals with EAE 
will demyelinate cultured tissue  does not necessarily signify a  similar role in 
vivo.  Recent theories  have emphasized  "delayed sensitivity" and cell-bound 
immune factors as opposed  to circulating  antibodies  as  explanations  for the 
etiology of EAE. Support for the "delayed sensitivity" theory has come from 
three main sources: (a)  the reported correlation  between skin testing and the 
incidence and severity of the disease (11); (b) the lack of correlation of incidence 
and severity of disease with circulating antibodies as measured by complement 
fixation titers (12); and (c) the passive transfer with cells but not serum (13). 
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of allergic encephalomyelitis  is obscured by the absence of a purified brain or 
cord extract which  contains the complete  biological activity of intact brain 
tissue (11). As a result a trace antigenic component unrelated to the production 
of encephalomyelitis  could be responsible for skin test activity (14, 15). 
A serum which demyelinates tissue culture may have no detectable comple- 
ment-fixing antibody versus brain tissue; and conversely a serum with comple- 
ment-fixing antibody may have no in dtro demyelinating antibody (16, 17). It 
is thus clear that no correlation  exists between complement  fixation tests for 
antibody and the myelinated tissue culture assay for antibody. The two tests 
may in  fact be  measuring  different antibodies  or  different amounts of  the 
same antibody. Less than one microgram of EAE gamma 2 globulin is required 
for in  dtro  demyelination, and this  amount may not be  detectable by the 
complement fixation technique.  One would then not be surprised  that comple- 
ment-fixing antibody titers do not parallel  the severity or even  the presence 
of EAE if the test is not sensitive enough to detect the presence of myelinolytic 
antibody. Therefore  a  failure to correlate  tests of circulating  antibody with 
the presence and severity of the disease would not exclude circulating antibody 
in the pathogenesis of experimental  allergic encephalomyelitis. 
The ability to transfer EAE with cells in ~i~o (13) or in vitro  (23) certainly 
represents  an important demonstration of the immunological character of the 
process but does not further define it because of the concomitant transfer of 
antibody-producing capacity. In fact, one of the tests of viability of the trans- 
ferred cells within the recipient  is the increasing levels of antibody produced 
(13). The question must then still be raised  as to whether antibody can be 
completely excluded in explaining development of brain lesions in the recipient. 
Although labeled lymphocytes will localize in the brain at sites of perivascular 
inflammation (18), the  specificity  of  such  localization  is  still  under  active 
investigation. The nucleic  acid and antibody constituents of the inoculated 
cells may act directly to produce the specific defect of EAE, or the macro- 
molecular components may function indirectly as specific transforming factors 
or inducers of the host lymphoid system. In any event the evidence at hand is 
inadequate to accept or  reject  the mediation of antibodies  in  the ultimate 
inflammatory and demyelinative lesions in vivo. 
The failure to transfer EAE in ~ivo with large amounts of serum is a serious 
objection to the etiological significance of circulating demyelinating antibodies, 
but need not invalidate an antibody mechanism.  Small amounts of a highly 
specific antibody may not achieve sufficient concentration at the myelin sheath 
and glial membrane both because  of serum dilution and more  significantly 
because of an intact "blood-brain" barrier which prevents direct access to the 
antigenic site. Myelinated cultures, on the other hand, provide both sensitivity 
and direct  access to  the myelin sheath and neuroglia.  Alteration of blood- 
brain permeability does in fact occur in EAE (19), and may represent the means 310  ALLERGIC  ENCEPHALOMYELITIS.  II 
by which a significant amount of specific antibody or antibody-producing cells 
gain access to the tissue. This is supported by the demonstration that electro- 
lytic brain lesions (20) and cyanide encephalopathy (21), both of which alter 
blood-brain  permeability,  localize  EAE  lesions in  the  affected  areas.  The 
pathology of  experimental  allergic  encephalomyelitis  would  then  be  deter- 
mined not  by a  single factor but  by several  possibly  independent factors: 
one of which may be directed against the vascular endothelium,  and others 
against the nerve tissues. 
The sera of all animals with EAE as well as of two animals with symptoms 
but no demonstrable  histological alteration possessed demyelinating antibody. 
The latter two cases are of extreme interest because they indicate that neuro- 
logical dysfunction may be associated  with minimal or  no light microscopic 
pathology despite  biochemical  or immunochemical  alterations. On  the other 
hand, these dam may also indicate that an antibody which results in demyelina- 
tion in vitro may be only one component of a series of factors responsible for the 
in vivo pathology. 
The significance of a demyelinative antibody in vivo is at present unknown. 
Yet, because of its specific and consistent biological activity in vitro, its possible 
role must be  considered in any explanation  of demyelination in animal and 
man. For demyelination in vivo the specific antibody may have to be produced 
in the brain by infiltrating lymphocytes to be present in sufficient concentration 
at the myelin sheath and glial membrane.  An initial induction of antibody at 
the lymph follicles by the inoculated antigen might result in low levels of serum 
antibody rendered  ineffectual in vivo by dilution and subsequent  inability to 
cross the blood-brain barrier in sufficient concentration. It may be undetectable 
by  techniques  such  as  complement  fixation,  yet may be  detectable  by its 
specific in vitro demyelinative activity. Subsequently,  an anamnestic response 
induced in sensitized lymphocytes by antigenic stimulation within the nervous 
system may exhibit biological activity because of direct access of the antibody 
to the antigenic site within the neural tissue. Such a theory is in accord  with 
known experimental  data and appears  testable with available  techniques. 
SUMMARY 
I. In the presence of  a source  of complement, the gamma 2 globulin  fraction 
of rabbit  EAE  serum results  in complete demyelination of myelinated cultures 
of rat cerebellum.  Exposure of the serum to homologous or heterologous brain 
specifically  removes the myelinotoxic activity  whereas exposure to non-nervous 
tissue  does not.  Polylysine  has  no effect  upon the  cultures  or  upon the  demyelin- 
ative  potency of  EAE, whereas heparin inhibits  activity  presumably through an 
effect  on complement. 
2. With  the  fluorescent antibody  technique, the  EAE  globulins are 
specifically  localized  to the myelin sheaths and glial  cell  membranes  during STANLEY  H. APPEL AND  MURRAY  B. BORNSTEIN  311 
the process of demyelination. As demyelination proceeds, the globulins become 
localized  within  the  neuroglia  in  a  homogeneous  manner  which  contrasts 
sharply with the punctate pattern observed in control experiments.  J 
3.  The  "delayed  sensitivity"  and  classical  antibody  interpretations  of 
experimental  allergic  encephalomyelitis  are  discussed.  It  is  suggested  that 
several factors may be responsible for the pathogenesis of EAE, one of which 
may well be a myelinotoxic antibody. 
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EXPLANATION OF PLATES 
PLATE 24 
FIG.  1.  Rat cerebellum. 27 days in vitro. Appearance of myelinated axons prior to 
exposure to a 25 per cent concentration of rabbit 14 serum. ×  450. 
FIG. 2.  Same field,  3 hours after exposure to EAE serum. Note the fragmentation 
of the myelinated axons and  the numerous irregularities  and  slight ballooning of the 
sheaths.  ×  450. 
FIG. 3.  Same field, 5 hours after exposure to EAE serum. By this time there has 
been  complete  disruption  of  the  myelinated  axons  which  gave  an  appearance  of 
linear strands in Fig. 1. The ballooning and fragments of Fig. 2 have disappeared to a 
large extent.  X 450. 
FIG. 4.  Same field.  Bodian silver impregnation of the culture fixed after 5 hours' 
exposure, indicating the intact axons and soma.  X  450. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 119  PLATE  24 
(Appel and Bornstein: Allergic encephalomyelitis. II) PLATV 25 
FIG. 5.  Rat cerebellar tissue  culture, 2 hours after exposure  to rabbit EAE serum 
(10 per cent).  Exposed  to duck anti-rabbit globulin labeled with fluorescein  isothio- 
cyanate. At this time there was Ilo visible evidence of demyelination. The fluorescent 
labeling, however,  indicates irregularities in the myelin sheath.  X  1000. 
FIG. 6.  Rat cerebellar tissue culture, 3 hours after exposure  to 20 per cent rabbit 
EAE  serum,  and during a  period  of  visible demyelination. Exposed  to  duck anti- 
rabbit globulin conjugated with fluorescein  isothiocyanate. Note marked ballooning 
of myelin sheaths and contiguous neuroglia. X 800. 
FIG. 7.  Rat cerebellar tissue culture, 3 hours after exposure  to  10 per cent rabbit 
EAE  serum,  during process  of  demyelination. Exposed  to  fluorescent duck  anti- 
rabbit globulin. There  is  scalloping of  myelin sheaths  as  well  as  discontinuities in 
each of the sheaths depicted.  X  500. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 119  PLATE  25 
(Appel and Bornstein: Allergic encephalomyelitis. II) PLATE 26 
FIG. 8.  Enlargement of a  section of  Fig.  7 emphasizing the  scalloping effect  and 
discontinuity in the affinity for fluorescent-labeled globulin. X  1000. 
FIG. 9.  Rat cerebellar tissue culture, 5 hours after exposure  to rabbit EAE serum 
(10  per  cent).  Exposed  to  fluorescent-labeled duck  anti rabbit globulin. Note  the 
homogeneous fluorescence  throughout  the  cytoplasm of  clusters of  neuroglial cells. 
X 45O. 
FiG. 10.  Rat cerebellar tissue culture, 5 hours after exposure to 25 per cent normal 
rabbit serum. Exposed  to duck anti-rabbit globulin labeled with fluorescein  isothio- 
cyanate. There is no affinity of the fluorescent-labeled globulin for myelin sheaths or 
neuroglial membranes. Instead the fluorescence  is present in a punetate distribution 
throughout neuroglial cells, most especially the microglial cells.  X  ,t50. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  119  PLATE  26 
(Appel and Bornstein: Allergic encephalomyelitis. II) 